Financhill
Buy
76

SPGI Quote, Financials, Valuation and Earnings

Last price:
$524.35
Seasonality move :
3.49%
Day range:
$517.21 - $526.52
52-week range:
$419.49 - $545.39
Dividend yield:
0.71%
P/E ratio:
41.04x
P/S ratio:
11.19x
P/B ratio:
4.80x
Volume:
1M
Avg. volume:
1.4M
1-year change:
18.65%
Market cap:
$160.2B
Revenue:
$14.2B
EPS (TTM):
$12.73
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $7.4B $8.3B $11.2B $12.5B $14.2B
Revenue Growth (YoY) 11.09% 11.49% 34.76% 11.77% 13.69%
 
Cost of Revenues $2.1B $2.2B $3.8B $4.1B $4.4B
Gross Profit $5.3B $6.1B $7.4B $8.4B $9.8B
Gross Profit Margin 71.86% 73.73% 66.43% 66.86% 69.1%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.5B $1.7B $3.4B $3.2B $3.2B
Other Inc / (Exp) -$232M $73M $2B -$49M $127M
Operating Expenses $1.7B $1.9B $4.4B $4.3B $4.3B
Operating Income $3.6B $4.2B $3B $4.1B $5.5B
 
Net Interest Expenses $141M $119M $304M $334M $297M
EBT. Incl. Unusual Items $3.2B $4.2B $4.7B $3.7B $5.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $694M $901M $1.2B $778M $1.1B
Net Income to Company $2.5B $3.3B $3.5B $2.9B $4.2B
 
Minority Interest in Earnings -$195M -$239M -$274M -$267M -$315M
Net Income to Common Excl Extra Items $2.3B $3B $3.2B $2.6B $3.9B
 
Basic EPS (Cont. Ops) $9.71 $12.56 $10.25 $8.25 $12.36
Diluted EPS (Cont. Ops) $9.66 $12.51 $10.20 $8.23 $12.35
Weighted Average Basic Share $241M $240.8M $316.9M $318.4M $311.6M
Weighted Average Diluted Share $242.1M $241.8M $318.5M $318.9M $311.9M
 
EBITDA $3.6B $4.5B $6B $5.1B $6.8B
EBIT $3.4B $4.3B $5B $4B $5.6B
 
Revenue (Reported) $7.4B $8.3B $11.2B $12.5B $14.2B
Operating Income (Reported) $3.6B $4.2B $3B $4.1B $5.5B
Operating Income (Adjusted) $3.4B $4.3B $5B $4B $5.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2B $2.4B $3.2B $3.5B $3.8B
Revenue Growth (YoY) 12.88% 18.5% 32.27% 10.48% 8.19%
 
Cost of Revenues $527M $749M $1.1B $1.1B $1.2B
Gross Profit $1.5B $1.6B $2.1B $2.4B $2.6B
Gross Profit Margin 73.86% 68.65% 65.57% 68.18% 69.47%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $360M $958M $705M $714M $764M
Other Inc / (Exp) $9M $1.4B $53M $15M $7M
Operating Expenses $410M $1.1B $992M $1B $1.1B
Operating Income $1.1B $545M $1.1B $1.4B $1.6B
 
Net Interest Expenses $32M $57M $85M $78M $78M
EBT. Incl. Unusual Items $1.1B $1.9B $1B $1.3B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $248M $568M $188M $248M $325M
Net Income to Company $808M $1.3B $860M $1.1B $1.2B
 
Minority Interest in Earnings -$53M -$64M -$65M -$77M -$81M
Net Income to Common Excl Extra Items $755M $1.2B $795M $991M $1.1B
 
Basic EPS (Cont. Ops) $3.14 $4.49 $2.47 $3.16 $3.55
Diluted EPS (Cont. Ops) $3.12 $4.47 $2.47 $3.16 $3.54
Weighted Average Basic Share $240.6M $275.2M $321.3M $313.6M $307.3M
Weighted Average Diluted Share $241.6M $276.3M $322.1M $314M $307.7M
 
EBITDA $1.1B $2.1B $1.4B $1.7B $1.9B
EBIT $1.1B $1.9B $1.1B $1.4B $1.6B
 
Revenue (Reported) $2B $2.4B $3.2B $3.5B $3.8B
Operating Income (Reported) $1.1B $545M $1.1B $1.4B $1.6B
Operating Income (Adjusted) $1.1B $1.9B $1.1B $1.4B $1.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $7.7B $8.7B $12B $12.8B $14.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1B $2.4B $4.1B $4.2B $4.4B
Gross Profit $5.6B $6.3B $7.9B $8.7B $10.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.6B $2.3B $3.1B $3.2B $3.2B
Other Inc / (Exp) -$230M $1.4B $662M -$87M $118M
Operating Expenses $1.8B $2.6B $4.3B $4.3B $4.4B
Operating Income $3.8B $3.7B $3.6B $4.4B $5.7B
 
Net Interest Expenses $139M $145M $332M $326M $297M
EBT. Incl. Unusual Items $3.4B $5B $3.9B $3.9B $5.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $754M $1.2B $800M $838M $1.2B
Net Income to Company $2.7B $3.8B $3.1B $3.1B $4.3B
 
Minority Interest in Earnings -$197M -$248M -$275M -$278M -$318M
Net Income to Common Excl Extra Items $2.5B $3.5B $2.8B $2.8B $4B
 
Basic EPS (Cont. Ops) $10.21 $13.91 $8.52 $8.94 $12.75
Diluted EPS (Cont. Ops) $10.16 $13.86 $8.50 $8.92 $12.73
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.8B $5.4B $5.4B $5.4B $7B
EBIT $3.5B $5.1B $4.2B $4.3B $5.8B
 
Revenue (Reported) $7.7B $8.7B $12B $12.8B $14.5B
Operating Income (Reported) $3.8B $3.7B $3.6B $4.4B $5.7B
Operating Income (Adjusted) $3.5B $5.1B $4.2B $4.3B $5.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2B $2.4B $3.2B $3.5B $3.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $527M $749M $1.1B $1.1B $1.2B
Gross Profit $1.5B $1.6B $2.1B $2.4B $2.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $360M $958M $705M $714M $764M
Other Inc / (Exp) $9M $1.4B $53M $15M $7M
Operating Expenses $410M $1.1B $992M $1B $1.1B
Operating Income $1.1B $545M $1.1B $1.4B $1.6B
 
Net Interest Expenses $32M $57M $85M $78M $78M
EBT. Incl. Unusual Items $1.1B $1.9B $1B $1.3B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $248M $568M $188M $248M $325M
Net Income to Company $808M $1.3B $860M $1.1B $1.2B
 
Minority Interest in Earnings -$53M -$64M -$65M -$77M -$81M
Net Income to Common Excl Extra Items $755M $1.2B $795M $991M $1.1B
 
Basic EPS (Cont. Ops) $3.14 $4.49 $2.47 $3.16 $3.55
Diluted EPS (Cont. Ops) $3.12 $4.47 $2.47 $3.16 $3.54
Weighted Average Basic Share $240.6M $275.2M $321.3M $313.6M $307.3M
Weighted Average Diluted Share $241.6M $276.3M $322.1M $314M $307.7M
 
EBITDA $1.1B $2.1B $1.4B $1.7B $1.9B
EBIT $1.1B $1.9B $1.1B $1.4B $1.6B
 
Revenue (Reported) $2B $2.4B $3.2B $3.5B $3.8B
Operating Income (Reported) $1.1B $545M $1.1B $1.4B $1.6B
Operating Income (Adjusted) $1.1B $1.9B $1.1B $1.4B $1.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.1B $6.5B $1.3B $1.3B $1.7B
Short Term Investments $9M $11M $14M $26M $20M
Accounts Receivable, Net $1.6B $1.7B $2.5B $2.8B $2.9B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $264M $323M $574M $1B $906M
Total Current Assets $6B $8.8B $5.7B $5.1B $5.5B
 
Property Plant And Equipment $778M $667M $720M $637M $678M
Long-Term Investments -- $165M $1.8B $1.8B $1.8B
Goodwill $3.7B $3.5B $34.5B $34.9B $34.9B
Other Intangibles $1.4B $439M $18.3B $17.4B $16.6B
Other Long-Term Assets $387M $234M $562M $536M $591M
Total Assets $12.5B $15B $61.8B $60.6B $60.2B
 
Accounts Payable $233M $205M $450M $557M $553M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- $47M $4M
Current Portion Of Capital Lease Obligations $100M $96M -- -- --
Other Current Liabilities $451M $600M $1.3B $1B $869M
Total Current Liabilities $3.6B $3.8B $6B $6.1B $6.4B
 
Long-Term Debt $4.1B $4.1B $10.7B $11.4B $11.4B
Capital Leases -- -- -- -- --
Total Liabilities $9.2B $9.5B $22B $22.5B $22.7B
 
Common Stock $294M $294M $415M $415M $415M
Other Common Equity Adj -$637M -$841M -$886M -$763M -$883M
Common Equity $509M $2B $36.4B $34.2B $33.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.8B $3.5B $3.4B $3.9B $4.3B
Total Equity $3.4B $5.5B $39.7B $38.1B $37.5B
 
Total Liabilities and Equity $12.5B $15B $61.8B $60.6B $60.2B
Cash and Short Terms $4.1B $6.5B $1.3B $1.3B $1.7B
Total Debt $4.1B $4.1B $11B $11.5B $11.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $4.5B $4.4B $1.4B $1.5B $1.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5B $2.4B $2.5B $3B $3.1B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $279M $548M $626M $845M $790M
Total Current Assets $6.3B $7.8B $5.8B $5.4B $5.3B
 
Property Plant And Equipment $760M $973M $703M $618M $678M
Long-Term Investments -- $1.6B $1.8B $1.8B $1.8B
Goodwill $3.7B $33.6B $34.8B $34.7B $35B
Other Intangibles $1.3B $21.2B $18.2B $17.1B $16.3B
Other Long-Term Assets $719M $897M $764M $788M $819M
Total Assets $12.8B $66.1B $62B $60.5B $59.9B
 
Accounts Payable $241M $410M $456M $458M $525M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- $66M $936M $301M $3M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $552M $1.1B $1.2B $985M $847M
Total Current Liabilities $3.4B $5.7B $6.4B $5.9B $5.9B
 
Long-Term Debt $4.1B $11.3B $10.7B $11.4B $11.4B
Capital Leases -- -- -- -- --
Total Liabilities $8.9B $22.9B $22.3B $22.2B $22.2B
 
Common Stock $294M $415M $415M $415M $415M
Other Common Equity Adj -$648M -$782M -$861M -$825M -$826M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.9B $3.5B $3.5B $3.9B $4.4B
Total Equity $3.9B $43.2B $39.8B $38.2B $37.7B
 
Total Liabilities and Equity $12.8B $66.1B $62B $60.5B $59.9B
Cash and Short Terms $4.5B $4.4B $1.4B $1.5B $1.5B
Total Debt $4.1B $11.4B $11.7B $11.7B $11.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $2.5B $3.3B $3.5B $2.9B $4.2B
Depreciation & Amoritzation $206M $178M $1B $1.1B $1.2B
Stock-Based Compensation $90M $122M $214M $171M $247M
Change in Accounts Receivable $18M -$144M $36M -$291M -$79M
Change in Inventories -- -- -- -- --
Cash From Operations $3.6B $3.6B $2.6B $3.7B $5.7B
 
Capital Expenditures $76M $35M $89M $143M $124M
Cash Acquisitions -$183M -$83M $3.7B $718M -$137M
Cash From Investing -$240M -$120M $3.6B $562M -$255M
 
Dividends Paid (Ex Special Dividend) -$645M -$743M -$1B -$1.1B -$1.1B
Special Dividend Paid
Long-Term Debt Issued $1.3B -- $5.4B $744M --
Long-Term Debt Repaid -$1.4B -- -$3.7B -$188M -$47M
Repurchase of Common Stock -$1.2B -- -$12B -$3.3B -$3.3B
Other Financing Activities -$255M -$283M $37M -$388M -$516M
Cash From Financing -$2.2B -$1B -$11.3B -$4.3B -$5B
 
Beginning Cash (CF) $2.9B $4.1B $6.5B $1.3B $1.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $2.5B -$5.1B -$8M $436M
Ending Cash (CF) $4.1B $6.5B $1.3B $1.3B $1.7B
 
Levered Free Cash Flow $3.5B $3.6B $2.5B $3.6B $5.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $808M $1.3B $860M $1.1B $1.2B
Depreciation & Amoritzation $50M $137M $287M $287M $293M
Stock-Based Compensation $19M $94M $46M $33M $47M
Change in Accounts Receivable $65M $187M $23M -$185M -$222M
Change in Inventories -- -- -- -- --
Cash From Operations $768M $222M $594M $948M $953M
 
Capital Expenditures $18M $16M $28M $24M $43M
Cash Acquisitions -$7M $2.9B -$222M -$1M -$13M
Cash From Investing -$24M $2.9B -$253M -$20M -$79M
 
Dividends Paid (Ex Special Dividend) -$186M -$186M -$290M -$286M -$295M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $5.4B $710M $250M --
Long-Term Debt Repaid -- -$3.1B -- -- -$4M
Repurchase of Common Stock -- -$7B -$500M -$500M -$650M
Other Financing Activities -$110M -$121M -$153M -$121M -$154M
Cash From Financing -$293M -$5.2B -$230M -$657M -$1.1B
 
Beginning Cash (CF) $4.1B $6.5B $1.3B $1.3B $1.7B
Foreign Exchange Rate Adjustment -$55M -$16M $7M -$18M $32M
Additions / Reductions $451M -$2.1B $111M $271M -$229M
Ending Cash (CF) $4.5B $4.4B $1.4B $1.5B $1.5B
 
Levered Free Cash Flow $750M $206M $566M $924M $910M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2.7B $3.8B $3.1B $3.1B $4.3B
Depreciation & Amoritzation $207M $265M $1.2B $1.1B $1.2B
Stock-Based Compensation $98M $197M $166M $158M $261M
Change in Accounts Receivable $7M -$22M -$128M -$499M -$116M
Change in Inventories -- -- -- -- --
Cash From Operations $3.7B $3.1B $3B $4.1B $5.7B
 
Capital Expenditures $83M $33M $101M $139M $143M
Cash Acquisitions -$7M $2.8B $584M $939M -$149M
Cash From Investing -$81M $2.8B $474M $795M -$314M
 
Dividends Paid (Ex Special Dividend) -$670M -$743M -$1.1B -$1.1B -$1.1B
Special Dividend Paid
Long-Term Debt Issued -- $5.4B $710M $284M -$250M
Long-Term Debt Repaid -- -$3.1B -- -$188M -$51M
Repurchase of Common Stock -$11M -$7B -$5.5B -$3.3B -$3.5B
Other Financing Activities -$270M -$294M $5M -$356M -$549M
Cash From Financing -$1.1B -$5.9B -$6.4B -$4.7B -$5.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.5B -$68M -$2.9B $152M -$64M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $3.6B $3B $2.9B $3.9B $5.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $808M $1.3B $860M $1.1B $1.2B
Depreciation & Amoritzation $50M $137M $287M $287M $293M
Stock-Based Compensation $19M $94M $46M $33M $47M
Change in Accounts Receivable $65M $187M $23M -$185M -$222M
Change in Inventories -- -- -- -- --
Cash From Operations $768M $222M $594M $948M $953M
 
Capital Expenditures $18M $16M $28M $24M $43M
Cash Acquisitions -$7M $2.9B -$222M -$1M -$13M
Cash From Investing -$24M $2.9B -$253M -$20M -$79M
 
Dividends Paid (Ex Special Dividend) -$186M -$186M -$290M -$286M -$295M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $5.4B $710M $250M --
Long-Term Debt Repaid -- -$3.1B -- -- -$4M
Repurchase of Common Stock -- -$7B -$500M -$500M -$650M
Other Financing Activities -$110M -$121M -$153M -$121M -$154M
Cash From Financing -$293M -$5.2B -$230M -$657M -$1.1B
 
Beginning Cash (CF) $4.1B $6.5B $1.3B $1.3B $1.7B
Foreign Exchange Rate Adjustment -$55M -$16M $7M -$18M $32M
Additions / Reductions $451M -$2.1B $111M $271M -$229M
Ending Cash (CF) $4.5B $4.4B $1.4B $1.5B $1.5B
 
Levered Free Cash Flow $750M $206M $566M $924M $910M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Why Mobileye Might Be Wall Street’s Next Big Surprise
Why Mobileye Might Be Wall Street’s Next Big Surprise

The trend to automate vehicles started long ago when adding…

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
99
SOC alert for May 20

Sable Offshore [SOC] is up 14.35% over the past day.

Buy
52
RGC alert for May 20

Regencell Bioscience Holdings [RGC] is down 10.93% over the past day.

Sell
40
GWLIF alert for May 20

Great-West Lifeco [GWLIF] is down 10.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock